Latest Information Update: 12 May 2005
At a glance
- Originator NatSpears
- Class Antineoplastics
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 12 May 2005 This programme is still in active development
- 15 Aug 2003 Preclinical trials in Cancer in Israel (unspecified route)